Evidence-based guideline: The role of diffusion and perfusion MRI for the diagnosis of acute ischemic stroke: Report of the therapeutics and technology assessment subcommittee of the american academy of neurology

Neurology

Volumn 75, Issue 2, 2010, Pages 177-185

  Schellinger, P D ^a,b   Bryan, R N ^c   Caplan, L R ^d   Detre, J A ^c   Edelman, R R ^e   Jaigobin, C ^f   Kidwell, C S ^g   Mohr, J P ^h   Sloan, M ⁱ   Sorensen, A G ^j   Warach, S ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

^f TORONTO GENERAL HOSPITAL   (Canada)

^g GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h Och Spine at New York Presbyterian Hospitals   (United States)

ⁱ UNIVERSITY OF SOUTH FLORIDA   (United States)

^j MASSACHUSETTS GENERAL HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN HEMORRHAGE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFUSION WEIGHTED IMAGING; DISEASE SEVERITY; EVIDENCE BASED PRACTICE; HUMAN; MEDICAL SOCIETY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; REVIEW;

EID: 77954749308     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181e7c9dd     Document Type: Article

References (40)

1. Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics: 2009 update: a report from the American Heart Association statistics committee and stroke statistics subcommittee. Circulation 2009;119:e21-e181.
2. Easton D, Saver JL, Albers GW, et al. Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council. Stroke 2009;40:2276-2293.
3. Adams HP Jr, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council. Stroke 2007;38:1655-1711.
4. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333: 1581-1587.
5. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317-1329.
6. del Zoppo GJ, Saver JL, Jauch EC, et al. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke 2009;40:2945-2948.
7. Fiebach JB, Schellinger PD, Gass A, et al. Stroke magnetic resonance imaging is accurate in hyperacute intracerebral hemorrhage: a multicenter study on the validity of stroke imaging. Stroke 2004;35:502-507.
8. Kidwell CS, Chalela JA, Saver JL, et al. Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA 2004;292:1823-1830.
9. von Kummer R, Allen KL, Holle R, et al. Acute stroke: usefulness of early CT findings before thrombolytic therapy. Radiology 1997;205:327-333.
10. Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy: ASPECTS Study Group Alberta Stroke Programme Early CT Score. Lancet 2000;355: 1670-1674
11. von Kummer R, Bozzao L, Manelfe C, eds. Early CT Diagnosis of Hemispheric Brain Infarction, 1st ed. Berlin: Springer Verlag; 1995.
12. Patel SC, Levine SR, Tilley BC, et al. Lack of clinical significance of early ischemic changes on computed tomography in acute stroke. JAMA 2001;286:2830-2838.
13. Fiebach JB, Schellinger PD, Jansen O, et al. CT and diffusion-weighted MR imaging in randomized order: diffusion-weighted imaging results in higher accuracy and lower interrater variability in the diagnosis of hyperacute ischemic stroke. Stroke 2002;33:2206-2210.
14. Schellinger PD, Fiebach JB, Hacke W. Imaging-based decision making in thrombolytic therapy for ischemic stroke: present status. Stroke 2003;34:575-583.
15. Warach S. Stroke neuroimaging. Stroke 2003;34:345-347.
16. Liu Y, Laakso MP, Karonen JO, et al. Apolipoprotein E polymorphism and acute ischemic stroke: a diffusion-and perfusion-weighted magnetic resonance imaging study. J Cereb Blood Flow Metab 2002;22:1336-1342.
17. Moseley ME, Cohen Y, Mintorovitch J, et al. Early detection of regional cerebral ischemia in cats: comparison of diffusion-and T2-weighted MRI and spectroscopy. Magn Reson Med 1990;14:330-346.
18. Rosen BR, Belliveau JW, Vevea JM, Brady TJ. Perfusion imaging with NMR contrast agents. Magn Reson Med 1990;14:249-265.
19. Buckley BT, Wainwright A, Meagher T, Briley D. Audit of a policy of magnetic resonance imaging with diffusion-weighted imaging as first-line neuroimaging for in-patients with clinically suspected acute stroke. Clin Radiol 2003; 58:234-237.
20. Schellinger PD, Jansen O, Fiebach JB, et al. Feasibility and practicality of MR imaging of stroke in the management of hyperacute cerebral ischemia. AJNR Am J Neuroradiol 2000;21:1184-1189.
21. von Kummer R. Imaging of stroke pathology without predefined gold standard. Cerebrovasc Dis 2002;14:270; author reply 271.
22. Albers GW, Thijs VN, Wechsler L, et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 2006;60:508-517.
23. Schellinger PD, Thomalla G, Fiehler J, et al. MRI-based and CT-based thrombolytic therapy in acute stroke within and beyond established time windows: an analysis of 1210 patients. Stroke 2007;38:2640-2645.
24. Davis SM, Donnan GA, Parsons MW, et al. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 2008; 7:299-309.
25. Furlan AJ, Eyding D, Albers GW, et al. Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke 2006;37:1227-1231.
26. Hacke W, Albers G, Al-Rawi Y, et al. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005;36:66-73.
27. Hacke W, Furlan AJ, Al-Rawi Y, et al. Intravenous des-moteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfu-sion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol 2009;8: 141-150.
28. Chalela JA, Kidwell C, Nentwich L, et al. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet 2007;369:293-398.
29. Barber PA, Hill MD, Eliasziw M, et al. Imaging of the brain in acute ischaemic stroke: comparison of computed tomography and magnetic resonance diffusion-weighted imaging. J Neurol Neurosurg Psychiatry 2005;76:1528-1533.
30. Grandin CB, Duprez TP, Smith AM, et al. Usefulness of magnetic resonance-derived quantitative measurements of cerebral blood flow and volume in prediction of infarct growth in hyperacute stroke. Stroke 2001;32: 1147-1153.
31. Karonen JO, Ostergaard L, Vainio P, et al. Diffusion and perfusion MR imaging in acute ischemic stroke: a comparison to SPECT. Comput Methods Programs Biomed 2001;66:125-128.
32. Schaefer PW, Hunter GJ, He J, et al. Predicting cerebral ischemic infarct volume with diffusion and perfusion MR imaging. AJNR Am J Neuroradiol 2002;23:1785-1794.
33. Wittsack HJ, Ritzl A, Fink GR, et al. MR imaging in acute stroke: diffusion-weighted and perfusion imaging parameters for predicting infarct size. Radiology 2002;222:397-403.
34. Linfante I, Llinas RH, Schlaug G, Chaves C, Warach S, Caplan LR. Diffusion-weighted imaging and National Institutes of Health Stroke Scale in the acute phase of posterior-circulation stroke. Arch Neurol 2001;58:621-628.
35. Fink JN, Selim MH, Kumar S, et al. Is the association of National Institutes of Health Stroke Scale scores and acute magnetic resonance imaging stroke volume equal for patients with right-and left-hemisphere ischemic stroke? Stroke 2002;33:954-958.
36. Lovblad KO, Baird AE, Schlaug G, et al. Ischemic lesion volumes in acute stroke by diffusion-weighted magnetic resonance imaging correlate with clinical outcome. Ann Neurol 1997;42:164-170. (Pubitemid 27340460)
37. Warach S, Pettigrew LC, Dashe JF, et al. Effect of citico-line on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging: Citicoline 010 Investigators. Ann Neurol 2000;48:713-722.
38. Baird AE, Dambrosia J, Janket S, et al. A three-item scale for the early prediction of stroke recovery. Lancet 2001; 357:2095-2099.
39. Thijs VN, Lansberg MG, Beaulieu C, Marks MP, Moseley ME, Albers GW. Is early ischemic lesion volume on diffusion-weighted imaging an independent predictor of stroke outcome? A multivariable analysis. Stroke 2000;31: 2597-2602.
40. Fiebach J, Jansen O, Schellinger P, et al. Comparison of CT with diffusion-weighted MRI in patients with hyper-acute stroke. Neuroradiology 2001;43:628-632.